Health Policy Monitor, Pharmaceutical Price Policy

Hofmarcher, Maria M. and Röhrling, Gerald (2003) Health Policy Monitor, Pharmaceutical Price Policy. Bertelsmann Stiftung, Health Policy Monitor Vol. 2003 No. 2. , 7 p.

[img]
Preview
Text
oa42.pdf - Published Version

Download (36kB) | Preview

Abstract or Table of Contents

The two main reasons for a future cost increase in the pharmaceutical sector in Austria are the demographic development and medical progress.In order to contain cost increases the policy purses two objectives: Introduction of a new price formation procedure and increased generic consumption to 20% of all prescribed drugs by 2006.

Item Type: Discussion/ Working Paper (Unspecified)
Keywords: Pharmaceutical Policy
Status: Published
Date Deposited: 06 Oct 2016 09:53
Last Modified: 23 Feb 2017 12:25
URI: http://irihs.ihs.ac.at/id/eprint/4075

Actions (login required)

View Item View Item